Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53

Molecular and Cellular Biology

Volumn 14, Issue 6, 1994, Pages 4183-4192

  Kelley, Linda L ^a,b,c   Green, Wayne F ^a,b   Hicks, Geoffrey G ^a   Bondurant, Maurice C ^a,b   Koury, Mark J ^a   Ruley, H Earl ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ERYTHROPOIETIN; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CONFORMATIONAL TRANSITION; ERYTHROID CELL; ERYTHROPOIESIS; GROWTH REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STABILITY; STEM CELL;

ANIMALIA; FRIEND MURINE LEUKEMIA VIRUS; MURINAE;

EID: 0028275077     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.14.6.4183     Document Type: Article

References (54)

1. Askew, D., R. Ashmun, B. Simmons, and J. Cleveland. 1991. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915-1922.
2. Askew, D., J. Ihle, and J. Cleveland. 1993. Activation of apoptosis associated with enforced Myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin. Blood 82:2079-2087.
3. Ben-David, Y., and A. Bernstein. 1991. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 66:831-834.
4. Berges, R., Y. Furuya, L. Remington, H. English, T. Jacks, and J. Isaacs. 1993. Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc. Natl. Acad. Sci. USA 90: 8910-8914.
5. Bernard, O., S. Cory, S, Gerodakis, E. Webb, and J. Adams. 1983. Sequence of the murine and human cellular myc oncogene and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumors. EMBO J. 12:2375-2383.
6. Boyer, S. H., T. R. Bishop, O. Rogers, A. N. Noyes, L. P. Frelin, and S. Hobbs. 1992. Roles of erythropoietin, insulin-like growth factor 1, and unidentified serum factors in promoting maturation of purified murine erythroid colony-forming units. Blood 80:2503-2512.
7. Clarke, A. R., C. A. Purdie, D. J. Harrison, R. G. Morris, C. C. Bird, M. L. Hooper, and A. H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (London) 362:849-852.
8. Cotter, T. G., J. M. Glynn, F. Echeverri, and D. R. Green. 1992. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res. 12:773-780.
9. Dai, C. H., S. B. Krantz, W. F. Green, and H. S. Gilbert. 1994. Polycythemia vera. III. Burst forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression. Br. J. Haematol. 86:12-21.
10. Darzynkiewicz, S., S. Bruno, G. Del Bino, W. Gorczyca, M. Hotz, P. Lassota, and F. Traganos. 1992. Features of apoptotic cells measured by flow cytometry. Cytometry 13:795-808.
11. Davis, L. G., M. D. Dibner, and J. F. Battey. 1986. Basic methods in molecular biology. Elsevier Science, New York.
12. Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1A which is inhibited by E1B. Genes Dev. 7:546-554.
13. Diller, L., J. Kassell, C. E. Nelson, M. A. Gryka, G. Litwak, M. Greghardt, and B. Bressac. 1990. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10:5772-5781.
14. Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, J. A. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (London) 356:215-220.
15. Feinberg, A., and B. Vogelstein. 1983. A technique for radiolabelling restriction endonuclease fragments to high specific activity. Biochemistry 132:6-13.
16. Gannon, J. V., R. Greaves, R. Iggo, and D. P. Lane. 1990. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J. 9:1595-1602.
17. Gorczyca, W., S. Bruno, R. J. Darzynkiewicz, J. Gong, and Z. Darzynkiewicz. 1992. DNA strand breaks occurring during apoptosis: their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int. J. Oncol. 1:639-648.
18. Hainaut, P., and J. Milner. 1993. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 53:4469-4473.
19. Harlow, E., L. Crawford, D. Pim, and N. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39:861-869.
20. Hofer, E., and J. Darnell. 1981. The primary transcription unit of the mouse beta-major globin transcript. Cell 23:585-593.
21. Johnson, P., S. Ghung, and S. Benchimol. 1993. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol. Cell. Biol. 13:1456-1463.
22. Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304-6311.
23. Kelley, L. L., M. J. Koury, and M. C. Bondurant. 1992. Regulation of programmed death in erythroid progenitor cells by erythropoietin: effects of calcium and of protein and RNA synthesis. J. Cell. Physiol. 151:487-496.
24. Kelley, L. L., M. J. Koury, M. C. Bondurant, S. T. Koury, S. T. Sawyer, and A. Wickrema. 1993. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood 82:2340-2352.
25. Kittrell, F., C. Oborn, and D. Medina. 1992. Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro. Cancer Res. 52:1924-1932.
26. Koury, M. J., and M. C. Bondurant. 1990. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248:378-381.
27. Koury, M. J., S. T. Sawyer, and M. C. Bondurant. 1984. Splenic erythroblasts in anemia-inducing Friend disease: a source of cells for studies of erythropoietin-mediated differentiation. J. Cell. Physiol. 121:526-532.
28. Landschulz, K. T., S. H. Boyer, A. N. Noyes, O. C. Rogers, and L. P. Frelin. 1992. Onset of erythropoietin response in murine erythroid colony-forming units: assignment to early S-phase in a specific cell generation. Blood 79:2749-2758.
29. Lin, D., M. Shields, S. Ulrich, E. Apella, and W. Mercer. 1992. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1-phase. Proc. Natl. Acad. Sci. USA 89:9210-9214.
30. Longmore, G. D., and H. F. Lodish. 1991. An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: a cytokine receptor superfamily oncogene. Cell 67:1089-1102.
31. Lowe, S., and H. E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by the adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7:535-545.
32. Lowe, S. W., H. E. Ruley, T. Jacks, and D. E. Housman. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
33. Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse tymocytes. Nature (London) 362:847-849.
34. Mercer, W. E., M. T. Shields, M. Amin, G. J. Suave, E. Appella, J. W. Romano, and S. J. Ullrich. 1990. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc. Natl. Acad. Sci. USA 87:6166-6170.
35. Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-681.
36. Minty, A., M. Caravatti, B. Robert, A. Cohen, P. Daubas, A. Weydert, F. Gros, and M. Buckingham. 1981. Mouse actin messenger RNAs. J. Biol. Chem. 256:1008-1014.
37. Mowat, M., A. Cheng, N. Kimura, A. Bernstein, and S. Benchimol. 1985. Rearrangements of cellular p53 gene in erythroleukemic cells transformed by Friend virus. Nature (London) 314:633-636.
38. Munroe, D. G., J. W. Peacock, and S. Benchimol. 1990. Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Mol. Cell. Biol. 10:3307-3313.
39. Muta, K., and S. Krantz. 1993. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor-1 as well as erythropoietin. J. Cell. Physiol. 156:264-271.
40. Ozbun, M., D. Jerry, F. Kittrell, D. Medina, and J. Butel. 1993. p53 mutations selected in vivo when mouse mammary cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro. Cancer Res. 53:1646-1652.
41. Ozbun, M., D. Medina, and J. Butel. 1993. p53 mutations in mouse mammary epithelial cells: instability in culture and discordant selection of mutations in vitro versus in vivo. Cell Growth Differ. 4:811-819.
42. Rogel, A., M. Popliker, C. Webb, and M. Oren. 1985. p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol. Cell. Biol. 5:2851-2855.
43. Ruscetti, S. K., N. J. Janesch, A. Chakraborti, S. T. Sawyer, and W. D. Hankins. 1990. Friend spleen focus-forming virus induces factor-independence in a erythropoietin-dependent erythroleukemia cell line. Virology 63:1057-1062.
44. Ryan, J. J., R. Danish, C. A. Gottlieb, and M. F. Clarke. 1993. Cell cycle analysis of p53-induced death in murine erythroleukemia cells. Mol. Cell. Biol. 13:711-719.
45. Sawyer, S. T., M. J. Koury, and M. C. Bondurant. 1987. Largescale procurement of erythropoietin-responsive erythroid cells, use in an assay for the biological activity of erythropoietin. Methods Enzymol. 147:340-352.
46. Shaw, P., R. Bovey, S. Tardy, R. Sahli, B. Sordat, and J. Costa. 1992. Induction of apoptosis by wild-type p53 in a human colon tumor derived cell line. Proc. Natl. Acad. Sci. USA 89:4495-4499.
47. Shimada, Y., G. Migliaccio, H. Shaw, and A. Migliaccio. 1993. Erythropoietin-specific cell cycle progression in erythroid subclones of the interleukin-3-dependent cell line 32D. Blood 81:935-941.
48. Spivak, J. L., T. Pham, M. Isaacs, and W. D. Hankins. 1991. Erythropoietin is both a mitogen and a survival factor. Blood 77:1228-1233.
49. Tsuda, H., T. Sawada, M. Kawakita, and K. Takatsuki. 1989. Mode of action of erythropoietin (Epo) in an Epo-dependent murine cell line. II. Cell cycle dependency of Epo action. Exp. Hematol. 17:218-222.
50. White, E. 1993. Minireview: regulation of apoptosis by the transforming genes of the DNA tumor virus adenovirus. Proc. Soc. Exp. Biol. Med. 204:30-39.
51. Yewdell, J., J. Gannon, and D. Lane. 1986. Monoclonal antibody analysis of p53 expression in normal and transformed cells. J. Virol. 59:444-452.
52. Yonish-Rouach, E., D. Grunwald, S. Wilder, A. Kimchi, E. May, J. Lawrence, P. May, and M. Oren. 1993. p53-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol. 13:1415-1423.
53. Yonish-Rouach, E., D. Resnitsky, J. Lotem, K. Sachs, A. Kim-Chi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (London) 352:345-347.
54. Yu, H., G. Bauer, G. K. Lipke, R. L. Phillips, and G. VanZant. 1993. Apoptosis and hematopoiesis in murine fetal liver. Blood 81:373-384.